PUBLICATIONS (1996- )
Psychiatric Genetics: Pharmacogenetics
Kohn, Y., Ebstein, R.P., Heresco-Levy, U., Shapira, B., Nemanov., L., Gritsenko, I., Avnon, M., Lerer, B.: Dopamine D4 receptor gene polymorphisms: Relation to ethnicity, schizophrenia and response to clozapine in Israeli subjects. European Neuropsychopharmacology 7: 39-43, 1997
Amar, A., Segman, R.H., Shtrussberg, S., Sherman, L., Safirman, C., Lerer, B., Brautbar, C.: Granulocytopenia in clozapine treated schizophrenia may be associated with HLA-DBQ1*0201. International Journal of Neuropsychopharmacology 1: 41-44, 1998.
Segman, R., Neeman, T., Heresco-Levy U., Finkel, B., Karagacev, L., Schlafman, M., Dorevitch, A., Yakir, A., Lerner, A., Shelevoy, A., Lerer, B.: Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Molecular Psychiatry 4: 247-253, 1999.
Segman, R.H., Lerer, B.: Genetic susceptibility to tardive dyskinesia in chronic schizophrenia: The potential role of candidate genes. In: Franzek, E., Ruther, E.,Ungvari GS, Beckmann, H. (Eds) Progress in Differentiated Psychopathology. Wuerzburg University Press, Wuerzburg, (In Press).
Segman, R.H., Heresco-Levy U., Finkel, B., Inbar, R., Neeman, T.,
Schlafman, M., Dorevitch, A., Yakir, A., Lerner, A., Shelevoy, A., Lerer,
B.: Association between the serotonin 2C receptor gene and tardive
dyskinesia in chronic schizophrenia; additive contribution of 5-HT2Cser and
DRD3gly alleles to susceptibility. Psychopharmacology (In Press).
|
